一般人们都认为美国药品费用上涨的原因是使用价格昂贵的全新药物,如治疗类风湿性关节炎的COX-2抑制剂等,但最近的4项药品价格研究结果表明,美国近几年药费迅速增长的主要原因是老产品的价格比较高,使用较广泛。分析表明,从1995年到1999年,每年处方药费用的增长幅度在12％到22％,其中,40％的增加是由于现有药品的价格升高,20％就是由于这些老产品处方量增加,新产品的高价格只影响20％。由于新产品而增加的处方量影响20％。 医生和病人都希望有最好的产品供他们使用,也希望他们能够支付得起新产品的费用。相反,制药厂商及其支持者称,新产品的价格反映了它们的价值,而药品价格的控制会影响企业的研究开发能力。工业批评家们认为应该增加 Most people think that the reason for the rising cost of medicines in the United States is the use of expensive new drugs such as COX-2 inhibitors for the treatment of rheumatoid arthritis. However, the results of the four recent drug price studies show that in the United States in recent years, The main reason for the rapid growth is that the prices of old products are relatively high and are widely used. Analysis shows that prescription drug costs increased by 12% to 22% per year from 1995 to 1999, of which 40% increase was due to the increase in the prices of existing medicines, 20% due to the increase in the prescriptions of these old products, The high price of new products affects only 20%. The increase in prescriptions due to new products affects 20%. Both doctors and patients want the best products for their use, and they also want them to be able to afford the new products. In contrast, pharmaceutical manufacturers and their backers say the prices of new products reflect their value, and the control of drug prices can affect the ability of an enterprise to research and develop. Industrial critics think it should increase